Masterclass: The Evolving Landscape of Digital Measures in Pharma

The evolving landscape of digital measures in pharma is a complex and dynamic field with emerging challenges and opportunities.

Digital measures in the pharma industry are becoming important as they are not only capable of speeding up the development of new drugs but also bridging the gap between the endpoint or biomarker and clinical need.

However, there are challenges - such as the cost of researching and developing digital measures - that must be overcome to argue in favour of  the validity and acceptance of digital measures in the pharma industry and beyond.

Join this meeting to learn more about how to navigate the evolving landscape of digital measures in pharma: 

• How will digital measures transform pharma in the next 3-5 years and what will this look like?  
• How can we navigate the challenges that pharma faces when integrating digital measures in drug development?  
• Taking stock: where does pharma stand on digital measures and what are the next big milestones the industry will need to meet?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.